Subscribe to RSS
DOI: 10.1055/s-2000-7748
© Johann Ambrosius Barth
Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in Type 2 diabetes
Publication History
Publication Date:
31 December 2000 (online)
Summary:
In this study we tested the hypothesis that the Leu7Pro7 polymorphism in prepro neuropeptide Y (NPY) gene could be a risk marker for the development of diabetic retinopathy and analyzed a well characterized cohort of patients with Type 2 diabetes followed-up for 10 years from the time of diagnosis. The frequency of Leu7/Pro7-polymorphism was 9.3% (8 out of 86). At baseline, the frequency of retinopathy in patients with the Leu7/Pro7-polymorphism was 25% (2 out of 8) and in those without it 6.4% (5 out of 78) (p = 0.126). At 10-year the respective figures were 88% and 50% (p = 0.040). The odds ratio for Leu7/Pro7-polymorphism in logistic regression analysis adjusted for age, gender and HbA1c was 8.97 (95% confidence intervals 1.09-98.0; p = 0.049). Our finding based on elderly Finnish Type 2 diabetic subjects suggests that the Leu7Pro7-genotype in preproNPY gene is associated with the development of diabetic retinopathy.
Key words:
NPY gene polymorphism - retinopathy - Type 2 diabetes
References
- 1 Karvonen M K, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker J M, Hart L M, Valve R, Uusitupa M IJ. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med. 4 1434-1437 1998;
- 2 Tomaszuk A, Simpson C, Williams G. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res. 46 53-58 1996;
- 3 Uusitupa M IJ, Niskanen L K, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 36 1175-1184 1993;
- 4 Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen W T, Kleinman H K, Grouzmann E, Grant D S. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 83 187-195 1998;
- 5 Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen G H, Myers A K, Wahlestedt C. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 14 263-268 1993;
Prof. Dr. Leo Niskanen
Department of Medicine, building no 5
University of Kuopio
P.O. Box 1627
FIN-70211 Kuopio, Finnland
Phone: +3 58-17-17 21 63 or + 3 58-17-16 27 80
Fax: +3 58-17-17 39 93
Email: leo.niskanen@kuh.fi